Merck (MRK) announced that Surendralal Karsanbhai, president and CEO, Emerson Electric (EMR), will join Merck’s board of directors effective January 1, 2025. He will stand for election by the company’s shareholders in May 2025. With the addition of Karsanbhai, the Merck board will consist of 13 members.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- U.S. FDA found asthma drug Singular, montelukast impacts the brain, Reuters says
- Pyxis Oncology announces preliminary PYX-201 data, collaboration with Merck
- Target reports downbeat Q3, Comcast plans cable TV spinoff: Morning Buzz
- Johnson & Johnson, Merck cutting jobs in China, Bloomberg reports
- Merck target upped at Jefferies after ‘important win’ with subcutaneous Keytruda